Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects with Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, RCT
As physicians, we will ensure easy access to the medication and professional guidance throughout the process
Tiong TS, Herington AC: Tissue distribution, characterization, and regulation of messenger ribonucleic acid for growth hormone receptor and serum binding protein in the rat
Treatment-related adverse events (any grade) occurred in 94% of patients
Compared to controls, simBOs derived from PD patients with the LRRK2 G2019S mutation exhibited increased LRRK2 activity, abnormal autophagy, and a decreased number of DA neurons, which were alleviated by the LRRK2 inhibitor PFE-360 (Ha et al., 2020)
They stimulate insulin secretion, reduce glucagon levels, slow gastric emptying, and promote feelings of fullness